Ambion Licenses RNA Stabilization Technology to Celera

Sep 06, 2002

NEW YORK, Sept. 6-Ambion's diagnostics division has licensed its RNA stabilization technology to Celera Diagnostics, the company said today.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.